MSMaryam Shafiee

Maryam Shafiee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maryam Shafiee has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Ali Ghaffarian-Bahraman

    Occupational Environment Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

    1 shared publication
  • Amir Hossein Hassani

    Shiraz University of Medical Sciences, Shiraz, Iran

    1 shared publication
  • Amirhossein Roshanshad

    Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

    1 shared publication
  • Babak Hosseini

    Laparascopy Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

    1 shared publication
  • Esmaeilian Saeed

    Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran

    1 shared publication
  • Fatemeh Masjedi

    Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

    1 shared publication

Latest Publications

  • Open Access

    Intradialytic blood pressure variability: prevalence, predictors, and consequences among hemodialysis patients and its relationship with sleep disorders

    by Seyed Amirreza Mazloumi, Hossein Fatemian, Maryam Shafiee, Amir Hossein Hassani

    Background: Chronic kidney disease (CKD) and end-stage renal disease (ESRD) pose significant health challenges worldwide, particularly in regions with limited access to advanced medical care. Dialysis, including hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD), remains essential in managing ESRD due to donor organ shortage. Understanding intradialytic blood pressure disorders is crucial for improving outcomes in HD patients. Methods: This cross-sectional study investigated the prevalence, predictors, and consequences of intradialytic blood pressure disorders among HD patients in Shiraz, Iran. Data were collected from 104 HD patients aged 18–75 years, with assessments including blood pressure measurements, laboratory data, dialysis settings, and other related parameters. Results: Significant blood pressure variability (BPV) during dialysis was observed in 59.6% of patients, with factors such as higher ultrafiltration amounts (p < 0.022), elevated plasma potassium levels (p < 0.018), and sleep disorders (p < 0.008) significantly associated with BPV. Intradialytic hypertension was linked to lower platelet counts (p < 0.001) and sleep disorders (p = 0.226), while intradialytic hypotension was associated with various factors including sleep medication use (p < 0.028), plasma potassium levels (p < 0.024), and gender (p = 0.021). Conclusions: Blood pressure variability during hemodialysis is common among HD patients, with factors such as ultrafiltration amounts, plasma potassium levels, and sleep disorders (as a novel factor) significantly influencing intradialytic blood pressure fluctuations. These findings underscore the complexity of managing blood pressure in HD patients and highlight the need for comprehensive assessment and tailored interventions to optimize patient care.


  • Open Access

    Assessment of the relationship between 25-hydroxyvitamin D and albuminuria in type 2 diabetes mellitus

    by Seyed Alireza Zomorodian, Maryam Shafiee, Zeinab Karimi, Fatemeh Masjedi, Amirhossein Roshanshad

    Background: Diabetic nephropathy occurs in about one-third of diabetic patients. This health problem is characterized by increased urinary albumin excretion, leading to decreased glomerular filtration rate and renal failure. In this regard, previous investigations have revealed the possibility of a relationship between vitamin D deficiency and diabetic nephropathy. The present study assessed the relationship between vitamin D deficiency and albuminuria in patients with type 2 diabetes. Methods: This study was conducted with 200 participants with type 2 diabetes mellitus from December 2019 to January 2021. The patients’ 25-hydroxyvitamin D (25OHD) serum level and urinary albumin-to-creatinine ratio (UACR) were measured concurrently. Afterward, the subjects were divided into three groups based on their albuminuria level. Finally, 25OHD serum level and other clinical characteristics were compared among these albuminuria groups, and the relation between albuminuria level and 25OHD was analyzed. Results: The prevalence of vitamin D deficiency in macroalbuminuric patients (UACR≥300 mg/g) was 61.8%, and in microalbuminuric (30 ≤ UACR< 300 mg/g) and normoalbuminuric groups (UACR< 30 mg/g) was 33.3% and 24%, respectively. Further analysis revealed a significant negative relationship between 25OHD and albuminuria(r = − 0.257, p-value< 0.001). According to ROC curve analysis, a 25OHD level ≤ 21 ng/ml was considered an optimal cut-off point value for having macroalbuminuria in diabetic patients. Conclusions: The current study evaluates the relation between vitamin D deficiency and the prevalence of albuminuria in the setting of diabetes. Overall, the prevalence of macroalbuminuria increased when the 25OHD serum level was less than 20 ng/ml.


  • Contamination of breast milk with lead, mercury, arsenic, and cadmium in Iran: a systematic review and meta-analysis

    by Salman Mohammadi, Maryam Shafiee, Seyed Nooreddin Faraji, Mohsen Rezaeian, Ali Ghaffarian-Bahraman

    Breast milk is a complete food for the development of the newborn, but it can also be an important route for environmental pollutants transmission to the infants. This study was aimed to evaluate the status of heavy metals including lead (Pb), mercury (Hg), cadmium (Cd) and arsenic (As) in the breast milk of Iranian mothers. The international databases including Scopus, PubMed, Web of Science and the Persian electronic databases including Scientific Information Database, IranMedex and Magiran were examined to find relevant articles published until July 2021. A total of 23 studies examined the levels of toxic metals in Iranian breast milk samples. According to the findings, the pooled average concentrations (µg/L) of Pb, Cd, Hg and As were 25.61, 2.40, 1.29 and 1.16, respectively. The concentration of Hg and Pb in colostrum milk was more than twice of mature milk. The Hg mean concentration in the breast milk of mothers with at least one amalgam-filled tooth was approximately three times that of mothers without amalgam-filled teeth. Risk assessment analysis indicated that the intake of Pb and Hg by infants through breastfeeding can be considered a health concern in Iran. It seems necessary to reduce the Pb exposure of pregnant and lactating women in Iran. However, more extensive studies are needed to clarify the toxic metals’ exposure status of infants through breast milk in other parts of the country.


  • Open Access

    Membranoproliferative glomerulonephritis in β-thalassemia intermedia; a case report

    by Maryam Shafiee, Seyed Alireza Zomorodian, Seyed Mohammad Owji, Jamshid Roozbeh Shahroodi, Mahsa Torabi Jahromi

    Introduction: β-thalassemia intermedia reduces the body’s ability to produce adult hemoglobin and causes anemia. In contrast to β-thalassemia major, β-thalassemia intermedia patients do not require lifelong transfusion and are often independent of blood transfusion until young age. Moreover, chronic hypoxia and iron overload may cause tubular and glomerular dysfunction in patients with thalassemia. Case Presentation: We report a 21-year-old female with β-thalassemia intermedia (β-TI) presenting with generalized edema and proteinuria and showed membranoproliferative glomerulonephritis (MPGN) after renal biopsy. Conclusion: The possibility of occurrence of MPGN in patients with thalassemia should be considered. To our knowledge, it is the first case of thalassemia that was reported with MPGN and, more investigation is required to assess the association of thalassemia and MPGN.

    • 1 March 2020
      • Vol. 14  (2) , 133-138

    Ambulatory Blood Pressure Monitoring in Hemodialysis Patients with Intradialytic Hypertension.

    by Maryam Shafiee, Shahrokh Ezzatzadegan Jahromi, Ghanbar Ali Raiss Jalali

    It has not yet been clear whether intradialytic hypertension (IDHN) translates into the presence of high BP between dialysis sessions or not. In this study, we aimed to perform interdialytic ambulatory blood pressure monitoring (ABPM) in patients with IDHN to find whether high BP persists at home. In this case-control study, ABPM was performed during a 44-hours interdialytic period in patients on maintenance hemodialysis (HD) with pre-dialysis systolic BP (SBP) above 130 mmHg. Bland- Altman graphs were used to investigate the magnitude of the difference between the results of ABPM records and intradialytic BP measurements in patients with and without IDHN. A total of 56 patients were enrolled in our study (29 in the IDHN group and 27 in the control group). The average of the pre-dialysis SBP in 6 consecutive HD treatments was 146.6 ± 11.36 vs. 146.8 ± 12.1 mmHg in IDHN and control group, respectively (P > .05). Mean post-dialysis SBP was 154.45 ± 12.6 mmHg in the IDHN group and 136.76 ± 11.50 in the control group (P < .001). Mean ± SD of 44-hour SBP was 157.31 ± 20.27 mmHg in the IDHN group, which was significantly higher than that in the control group (146.5 ± 16.67 mmHg, P < .05). No significant differences were seen in the average of interdialytic weights gain between the two groups. Compared to the pre-dialysis SBP, using Bland- Altman graphs, the post-dialysis SBP (bias of 3.5 mmHg) had closer readings to the daytime SBP in the IDHN group. Patients with IDHN had higher interdialytic BPs. Among BPs taken during HD in patients with IDHN, post-dialysis SBP had the lowest difference with the daytime SBP taken by ABPM.


  • Serum cytokeratin 18 level is associated with dietary intake and serum triglycerides level in hemodialysis patients

    by Zahra Sohrabi, Neda Haghighat, Morteza Zare, Nader Moein Vaziri, Babak Hosseini, Hadi Bazyar, Meysam Alipour, Maryam Shafei

    Cell death leads to increase serum cytokeratin 18 (CK-18) in chronic kidney disease. However, few studies have investigated the serum CK-18 level in relation to nutritional and metabolic biomarkers. We examined the association of dietary intake and lipid profile with serum CK18 level among hemodialysis (HD) patients. Ninety HD patients according to inclusion and exclusion criteria were included in the study. An analysis of clinical characteristics, anthropometric indices, dietary intake, and lipid profile revealed a significant association between serum CK-18 and diabetes, metabolic syndrome, body mass index (BMI), triglyceride (TG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), energy intake (EI), protein intake (PI), and saturated fatty acid (SFA). In a multiple stepwise regression model, after adjusting for confounders in three models, the association between serum CK-18 and serum TG level, dietary SFA and EI remained significant. The model 3 adjusted for DM, Mets, BMI, ALT, AST, and PI; model 2 adjusted for model 1 + EI; and model 1 adjusted for model 2 + SFA. Our findings suggest that the development of hypertriglyceridemia and inadequate EI contribute to higher serum CK-18, which is a cell death biomarker.